|
Role of cAMP signalling in the
developmental transformation of Leishmania donovani |
| Principal Investigator : Parmeshwari Sahai
The
main theme of the project is to understand molecular basis of transformation
of promastigotes into amastigotes in terms of signalling events mediated by
cAMP. The objectives of the project are (i) to study in vitro developmental
transformation of Leishmania donovani in presence of activators and inhibitors
of adenylyl cyclases, cAMP-phosphodiesterases (cAMP-PDEs), and protein kinase
A (PKA), (ii) identification of adenylyl cyclase, cAMP-PDE, and PKA in
different developmental stages of the parasite, and (iii) purification and
characterization of adenylyl cyclase, cAMP-PDE and PKA from the parasite. A
pre-requisite of this project was to have consistent supply of amastigotes.
We, thus, first attempted axenization of the parasite Leishmania donovani (DD8
strain). During axenization we chose four successive developmental stages
viz., procyclic promastigote (4 days old promastigotes), metacyclic
promastigote (7 days old promastigotes), temperature transformant (metacyclic
promastigotes shifted to 350C at pH 7.2), and axenic amastigote (temperature
transformants shifted to pH 5.5 at 350C). Initial attempt was made in medium
199 with HI-FBS. During the process, it was learnt that axenic amastigotes
couldn’t survive after 3-4 days. Moreover, this medium was fortified with
heat-inactivated FBS (HI-FBS) and hence was not suitable for biochemical
manipulations. We then shifted to a completely defined medium, dDME, which is
basically DMEM fortified with several growth factors and lipid-free BSA in
place of HI-FBS. An acidic pH (5.5) was used for amastigote stage, which was
close to the pH of phagolysosomal compartment. Amastigotes not only survived
in this medium but also could be propagated for few generations at a higher
split ratio. Light and electron microscopies, biochemical analyses, metabolic
labeling, infectivity, and back transformation were used to characterize these
stages. After
achieving well-characterized amastigotes intracellular level of cAMP was
measured in all the four stages using competitive EIA. Intrinsic
phosphodiesterase activity was killed and intracellular cAMP was stabilized by
using 0.1 M HCl. Estimation of intracellular concentration of cAMP revealed
approximately eight-fold higher levels of the second messenger in axenic
amastigotes than in procyclic promastigotes under normal conditions. In
presence of a specific inhibitor of adenylyl cyclase, 22 ,52 -dideoxyadenosine
(5 mM), the corresponding levels of cAMP were marginally different and the
transformation of promastigotes to amastigotes seemed arrested. In
order to further probe the role of cAMP in the transformation process back
transformation was done in presence of phosphodiesterase (PDE) inhibitors. 5 x
108 axenic amastigotes were back transformed with either IBMX or etazolate or
rolipram. IBMX is a non-specific PDE inhibitor. At a concentration of 4 mM
IBMX could inhibit transformation of amastigotes into promastigotes. Rolipram
and etazolate are cAMP-specific PDE inhibitors (type IV cAMP-PDE). 0.5 mM
rolipram and 1 mM etazolate were found sufficient to stop back transformation.
Microscopic observations were made for accompanying morphological changes. These
data put together suggest that in the transformation of promastigotes to
amastigotes cAMP level goes up and stays there. So long as this high cAMP
level is maintained, the transformation process can’t be reversed. In other
words higher cAMP levels favour transformation of promastigotes to amastigotes
and lower levels of cAMP favour transformation of amastigotes to promastigotes.
Also that the intracellular cAMP level drastically changes between metacyclic
promastigotes and temperature transformant. During
the reporting year, we were also able to identify a kinase activity in the
metacyclic promastigotes that was cAMP-dependent. This was made possible by
using biotinylated Kemptide as substrate and a highly specific biotin capture
membrane, and lysing the cells in presence of sodium orthovanadate and
etazolate hydrochloride in addition to protease inhibitor cocktail. Under
these conditions the kinase activity almost doubled in presence of cAMP. This
is for the first time that PKA activity is being demonstrated in Leishmania
parasite. Use of specific inhibitors of PKA would confirm this observed
activity. Evaluation of status of PKA activity in various developmental stages
is warranted. During
the reporting period we also tried to identify and purify PDE from metacyclic
promastigotes. 1010 cells were lysed in presence of protease inhibitors,
benzamidine, and NaBr. PDE activity in the cytosolic portion was assayed by
measuring unused cAMP in the reaction mixture after a fixed interval of
incubation of cAMP with it. After confirming the presence of PDE activity in
the cytosol, purification was attempted on Cibacron Blue-F3GA-agarose column.
PDE activity was eluted with a linear gradient of NaCl after recycling the
cytosolic fraction through the column o/n and then thorough washing. The main
peak was pooled and analysed for PDE activity. Further characterization of PDE
activity is going on. Attempts are also being made to see the status of
cytosolic PDE in different developmental stages. |